A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma

Clinical trial NCT00661336 · WITHDRAWN

Trial details

NCT number: NCT00661336
Sponsor: Duke University
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2008-04-01
Primary completion: 2009-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.